Adalimumab (Humira) Prefilled Syringe from Canada
Adalimumab is a fully human monoclonal antibody inhibiting TNF-alpha, for rheumatoid arthritis and Crohn's disease. It qualifies for HTS 3002.15.00.11 as a measured-dose immunological product for retail sale, regulating immune processes per chapter notes.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Secure prior FDA notice and biologics import license; validate TNF-targeting mechanism in docs
• Use insulated packaging with temperature monitors; declare exact measured doses per syringe